ClinicalTrials.Veeva

Find clinical trials for Diabetes in Toronto, ON

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near Toronto, ON, CAN:

Empagliflozin and the Preservation of Beta-cell Function in Women With Recent Gestational Diabetes (EMPA post-GDM)

Double-blind, parallel arm, randomized controlled trial, in which non-lactating women with recent GDM who are between 6 to 36 months postpartum to be...

Enrolling
Gestational Diabetes
Drug: Empagliflozin 10 MG
Drug: Placebo oral capsule

Phase 3

Mount Sinai Hospital, Canada

Toronto, Ontario, Canada

inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...

Not yet enrolling
Diabetic Nephropathies
Diabetes Mellitus Type 1
Drug: Sotagliflozin
Drug: Placebo

Phase 3

Alessandro Doria

Toronto, Ontario, Canada and 18 other locations

In type 1 diabetes (T1D), immune defense cells in the body attack and destroy insulin-producing beta cells leaving affected people with a li...

Enrolling
Type 1 Diabetes Mellitus
Drug: Ustekinumab
Drug: Placebo

Phase 2, Phase 3

University of British Columbia
University of British Columbia

Toronto, British Columbia, Canada and 1 other location

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Active, not recruiting
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)

Phase 3

Prokidney

Oshawa, Ontario, Canada and 45 other locations

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Tirzepatide
Drug: Antihyperglycemic medication

Phase 4

Lilly
Lilly

Stouffville, Ontario, Canada and 88 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Placebo (semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Toronto, Ontario, Canada and 173 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Toronto, Ontario, Canada and 78 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Toronto, Ontario, Canada and 636 other locations

The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D)....

Enrolling
Type 1 Diabetes
Drug: VX-264

Phase 1, Phase 2

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Toronto, Canada and 12 other locations

Phase 2 Trial of BMF-219 in Participants with Type 1 Diabetes Mellitus....

Enrolling
Type 1 Diabetes Mellitus
Drug: BMF-219

Phase 2

Biomea Fusion

Toronto, Ontario, Canada and 24 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems